UniSuper, IFM buy majority stake in PRP Diagnostics
Thursday, March 5, 2026 · first reported by www.superreview.com.au
IFM Investors and UniSuper acquired a majority stake in PRP Diagnostics, an Australian leading diagnostic imaging provider. Material portfolio acquisition by major institutional investors.
- Firm
- IFM Investors
- Also named
- UniSuper, PRP Diagnostics
- Asset class
- Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.